Webdisclosure.com

Search

UCB (EBR:UCB) UCB Media Room: Acquisitions and disposals of own shares

Directive transparence : information réglementée

02/04/2021 20:04
https://mb.cision.com/Public/18595/3319421/a3bbb366049fc05e_800x800ar.jpg ** Acquisitions of own shares and disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 2 April 2021 =E2=80=93 20:00 (CEST) =E2=80=93 regulated= information Acquisitions of own shares In accordance with article 8:4 of the Royal Decree of 29 April 2019 executi= ng the Belgian Code on Companies and Associations, UCB SA/NV (=E2=80=9CUCB= =E2=80=9D or the =E2=80=9CCompany) (Euronext Brussels: UCB) hereby disclose= s certain information in relation to its Share Repurchase Program 2021.=C2= =A0 Under this program, UCB has requested a financial intermediary to repurchas= e up to 750 000 UCB shares on its behalf under the terms of an initial disc= retionary mandate agreement with validity until 25 June 2021, effective as = from 8 March 2021, to cover current and future obligations under UCB's Long= Term Incentive Plans for its personnel. In the framework of this Share Repurchase Program 2021, UCB repurchased 76 = 373 UCB shares on Euronext Brussels in the period from 26 March 2021 up to = and including 1st April 2021, as follows:=C2=A0 https://mb.cision.com/Public/18595/3319421/a27df9a6fe54b17e_800x800ar.png Disposal of own shares In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel, it has disposed of UCB shares = OTC in view of deliveries of these shares to the relevant members of the pe= rsonnel, within the framework of the Long Term Incentive Program of the UCB= Group, as follows: https://mb.cision.com/Public/18595/3319421/92bf5aa9c95b67b3_800x800ar.png =C2=A0 In addition to these exercises, on 1 April 2021, in accordance with the ves= ting rules under its 2018 LTI plans, UCB SA/NV has delivered for free a tot= al of 408 810 UCB shares OTC to 1 439 members of the personnel of the Compa= ny and its subsidiaries. The highest independent bid price on Euronext Brus= sels on 1 April 2021 was =E2=82=AC 81.60. This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 =C2=A0=C2=A0 =C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 400 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.3 bi= llion in 2020. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news GenericFile 210402 - UCB Acquisitions and disposals of own shares ENG final (https://mb= .cision.com/Public/18595/3319421/a202e7b56c7eaabd.pdf) GenericFile 210402- Verwerving en vervreemding van eigen aandelen NED (https://mb.cisio= n.com/Public/18595/3319421/a713559b83d75513.pdf) GenericFile 210402- Rachat et ali=C3=A9nation d actions propres FR (https://mb.cision.c= om/Public/18595/3319421/9d05f63bb7b4af74.pdf) Image Capture 1 April 2 2021 (https://mb.cision.com/Public/18595/3319421/a27df9a6= fe54b17e_org.png) Image Capture 2 April 2 2021 (https://mb.cision.com/Public/18595/3319421/92bf5aa9= c95b67b3_org.png)=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x65665x1x6868579x24000= x6&Email=3Dregnews%40symexglobal.com.=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=